0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query mrrpb5 global orphan diseases market size status forecast 2019 2025.Your search for "" gave back 1533058 results.
Interleukin 1 Receptor Type 1 - Pipeline Review, H2 2019 Summary Interleukin 1 Receptor Type 1 (CD121 Antigen Like Family Member A or Interleukin 1...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Acquired orphan blood disease is a type of rare blood disorder, which occurs due to the presence of insufficient amount of red blood cells in the...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
The global Biologic Response Modifiers market size was valued at US$ million in 2023. With growing demand in downstream market, the Biologic Response...
Catalog:
LPI
March 2024
Price: USD 3,660.00
The global Essential Thrombocythemia Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Essential...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Retinal disorders therapy includes medical interventions and treatments used to manage various retinal disorders, such as age-related macular...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Coccidioidomycosis - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
March 2019
Price: USD 2,000.00
Canavan Disease (Central Nervous System) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare...
Catalog:
Global Markets Direct
November 2021
Price: USD 2,000.00
Canavan Disease - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Canavan...
Catalog:
Global Markets Direct
June 2020
Price: USD 2,000.00
Prosthetic joint infections - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
Catalog:
Global Markets Direct
December 2019
Price: USD 2,000.00
Signifor is an orphan drug approved in the United States and Europe for the treatment of Cushing's disease in patients who fail or are...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Pasireotide is an orphan drug approved in the United States and Europe for the treatment of Cushing's disease in patients who fail or are...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Cryptococcosis (Infectious Disease) - Drugs In Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
June 2021
Price: USD 2,000.00
Canavan Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's...
Catalog:
Global Markets Direct
November 2022
Price: USD 2,000.00
N Sulphoglucosamine Sulphohydrolase - Pipeline Review, H2 2019 Summary N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Glucagon Like Peptide 2 Receptor - Pipeline Review, H1 2019 Summary According to the recently published report 'Glucagon Like Peptide 2 Receptor...
Catalog:
Global Markets Direct
May 2019
Price: USD 3,500.00
